Study #2024-0501
Phase 2 study of ivonescimab in patients with cutaneous squamous cell carcinoma
MD Anderson Study Status
Enrolling
Treatment Agent
Ivonescimab
Description
To learn if ivonescimab can help to control advanced cSCC. The safety and effects of ivonescimab will also be studied.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Cutaneous Squamous Cell Carcinoma
Study phase:
Phase II
Physician name:
Aung Naing
Department:
Investigational Cancer Therapeutics
For general questions about clinical trials:
1-855-773-0951
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.